Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
Review of earlier studies · 2017
- What was studied
- 442 participants in the pooled CARS-1 and CARS-2 analysis
- Main finding
- Individual-participant analysis reports a favorable motor-recovery result during early rehabilitation.
ARAT at day 90 · Mann–Whitney effect size 0.62 · p<0.0001
Reported findings and study design
Individual-patient meta-analysis of CARS-1/2; 442 patients. Cerebrolysin 30 mL/day for three weeks starting 24–72 hours after stroke; standardized 21-day rehabilitation.
Population or model 442 participants in the pooled CARS-1 and CARS-2 analysis
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| ARAT at day 90 | Mann–Whitney effect size 0.62 | p<0.0001 |
| Early NIHSS at days 14/21 | Mann–Whitney effect size 0.59 | p<0.002 |
| NNT for clinically relevant early NIHSS change | 7.1; 95% CI 4–22 |
Combines two trials already represented elsewhere. Mann–Whitney estimates are not percentage improvements; last-observation-carried-forward analysis was used.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Reanalysis of existing trials, not a new independent cohort. The CARS totals already include these participants.
Source details
Journal publication
Citation and indexed abstract checked. Full methods, funding and risk of bias have not been comprehensively appraised.
Sources checked
Citation
Guekht A, Vester J, Heiss WD, Gusev E, Hoemberg V, Rahlfs VW, Bajenaru O, Popescu BO, Doppler E, Winter S, Moessler H, Muresanu D. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Study source ↗ · DOI 10.1007/s10072-017-3037-z · Bibliography entry · Link to this summary